Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Pelegrino, Flavia S A ^a   Volpe, Eugene A ^a   Gandhi, Niral B ^a   Li, De Quan ^a   Pflugfelder, Stephen C ^a   de Paiva, Cintia S ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE; MUSCARINIC M3 RECEPTOR;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LYSATE; CONTROLLED STUDY; DACRYOCYSTITIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE DELETION; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY; SJOEGREN SYNDROME; WESTERN BLOTTING; 129 MOUSE; ANIMAL; B LYMPHOCYTE; BLOOD; C57BL MOUSE; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LACRIMAL APPARATUS; LACRIMAL FLUID; MALE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TIME;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DACRYOCYSTITIS; EPIDERMAL GROWTH FACTOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LACRIMAL APPARATUS; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, MUSCARINIC M3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TEARS; TIME FACTORS;

EID: 84868236551     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4077     Document Type: Article

References (48)

1. Andrianakos A, Trontzas P, Christoyannis F, Dantis P, Voudouris C, Georgountzos A, Kaziolas G, Vafiadou E, Pantelidou K, Karamitsos D, Kontelis L, Krachtis P, Nikolia Z, Kaskani E, Tavaniotou E, Antoniades C, Karanikolas G, Kontoyanni A. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study: The ESORDIG Study. J Rheumatol 2003, 30:1589-1601.
2. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjogren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998, 37:1069-1076. 10.1093/rheumatology/37.10.1069, 9825745.
3. Kong L, Robinson CP, Peck AB, Vela-Roch N, Sakata KM, Dang H, Talal N, Humphreys-Beher MG. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 1998, 16:675-681.
4. Brayer JB, Cha S, Nagashima H, Yasunari U, Lindberg A, Diggs S, Martinez J, Goa J, Humphreys-Beher MG, Peck AB. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren's syndrome. Scand J Immunol 2001, 54:133-140. 10.1046/j.1365-3083.2001.00958.x, 11439159.
5. Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol 2004, 60:552-565. 10.1111/j.0300-9475.2004.01508.x, 15584966.
6. Cha S, Peck AB, Humphreys-Beher MG. Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update. Crit Rev Oral Biol Med 2002, 13:5-16. 10.1177/154411130201300103, 12097234.
7. Jabs DA, Prendergast RA, Campbell AL, Lee B, Akpek EK, Gerard HC, Hudson AP, Whittum-Hudson JA. Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci 2007, 48:5624-5629. 10.1167/iovs.07-0237, 2215323, 18055812.
8. Nguyen CQ, Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf 2009, 7:11-27. 10.1016/S1542-0124(12)70289-6, 2861866, 19214349.
9. Rahimy E, Pitcher JD, Pangelinan SB, Chen W, Farley WJ, Niederkorn JY, Stern ME, Li D-Q, Pflugfelder SC, de Paiva CS. Spontaneous autoimmune dacryoadenitis in aged CD25KO mice. Am J Pathol 2010, 177:744-753. Epub 2010 Jun 21, 10.2353/ajpath.2010.091116, 2913359, 20566743.
10. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699. 10.1038/359693a0, 1436033.
11. McCartney-Francis NL, Mizel DE, Redman RS, Frazier-Jessen M, Panek RB, Kulkarni AB, Ward JM, McCarthy JB, Wahl SM. Autoimmune Sjogren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides. J Immunol 1996, 157:1306-1312.
12. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261. 10.1016/0092-8674(93)80067-O, 8402910.
13. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995, 3:521-530. 10.1016/1074-7613(95)90180-9, 7584142.
14. de Paiva CS, Hwang CS, Pitcher JD, Pangelinan SB, Rahimy E, Chen W, Yoon KC, Farley WJ, Niederkorn JY, Stern ME, Li D-Q, Pflugfelder SC. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) 2010, 49:246-258. Epub 2009 Dec 9.
15. Buckingham RS, McDuffie D, Whitwell K, Lee RB. Follow-up study on vision health readiness in the military. Mil Med 2003, 168:789-791.
16. Rice BA, Foster CS. Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990, 97:1476-1483.
17. Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Br J Dermatol 2006, 154:319-324. 10.1111/j.1365-2133.2005.07023.x, 16433803.
18. Rojas B, Cuhna R, Zafirakis P, Ramirez JM, Lizan-Garciia M, Zhao T, Foster CS. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res 2005, 81:313-325. 10.1016/j.exer.2005.02.004, 16129099.
19. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997, 15:749-795. 10.1146/annurev.immunol.15.1.749, 9143706.
20. de Paiva CS, Villarreal AL, Corrales RM, Rahman HT, Chang VY, Farley WJ, Stern ME, Niederkorn JY, Li D-Q, Pflugfelder SC. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-{gamma}. Invest Ophthalmol Vis Sci 2007, 48:2553-2560. 10.1167/iovs.07-0069, 17525184.
21. Konno A, Takada K, Saegusa J, Takiguchi M. Presence of B7-2+ dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IqI/Jic mouse model of primary Sjorgren's syndrome. Autoimmunity 2003, 36:247-254. 10.1080/0891693031000141077, 14563019.
22. de Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KS, Niederkorn JY, Stern ME, Li D-Q, Pflugfelder SC. IL-17 disrupts corneal barrier following desiccating stress. Mucos Immunol 2009, 2:243-253. Epub 2009 Feb 25.
23. Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios IK, Kogopoulou O, Moutsopoulos HM, Thyphronitis G. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol 2002, 128:562-568. 10.1046/j.1365-2249.2002.01869.x, 1906267, 12067313.
24. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 2006, 54:1165-1173. 10.1002/art.21764, 16572451.
25. Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA, Peen E, Jonsson R, Humphreys-Beher MG. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome. Proc Natl Acad Sci USA 1998, 95:7538-7543. 10.1073/pnas.95.13.7538, 22675, 9636185.
26. Zoukhri D, Hodges RR, Byon D, Kublin CL. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci 2002, 43:1429-1436. 3241052, 11980857.
27. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res 2006, 82:885-898. 10.1016/j.exer.2005.10.018, 1361268, 16309672.
28. Pitcher JD, De Paiva CS, Pelegrino FS, McClellan AJ, Raince JK, Pangelinan SB, Rahimy E, Farley WJ, Stern ME, Li D-Q, Pflugfelder SC. Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland. Invest Ophthalmol Vis Sci 2011, 52:3221-3227. 10.1167/iovs.09-4212, 3109024, 21273534.
29. Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Invest Ophthalmol Vis Sci 2001, 42:321-327.
30. Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 1998, 39:151-156.
31. Fantes FE, Hanna KD, Waring GO, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 1990, 108:665-675. 10.1001/archopht.1990.01070070051034, 2334323.
32. Fox RI, Kang HI. Pathogenesis of Sjogren's syndrome. Rheum Dis Clin North Am 1992, 18:517-538.
33. Lam H, Blieden L, de Paiva CS, Farley WJ, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 2009, 147:198-205. Epub 2008 Nov 7, 10.1016/j.ajo.2008.08.032, 18992869.
34. Zoukhri D, Macari E, Kublin CL. A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Exp Eye Res 2007, 84:894-904. 10.1016/j.exer.2007.01.015, 3234164, 17362931.
35. Zoukhri D, Ko S, Stark PC, Kublin CL. Roles of caspase 1 and extracellular signal-regulated kinase in inflammation-induced inhibition of lacrimal gland protein secretion. Invest Ophthalmol Vis Sci 2008, 49:4392-4398. 10.1167/iovs.08-1830, 2568975, 18566460.
36. Zoukhri D, Fix A, Alroy J, Kublin CL. Mechanisms of murine lacrimal gland repair after experimentally induced inflammation. Invest Ophthalmol Vis Sci 2008, 49:4399-4406. 10.1167/iovs.08-1730, 2568973, 18586880.
37. Zoukhri D, Macari E, Choi SH, Kublin CL. c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion. J Neurochem 2006, 96:126-135. 10.1111/j.1471-4159.2005.03529.x, 1414092, 16300639.
38. Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, Hansell E, Kurup VP, Warnock M, Grunig G. IL-13 and IFN-gamma: interactions in lung inflammation. J Immunol 2001, 167:1769-1777.
39. Irifune K, Yokoyama A, Sakai K, Watanabe A, Katayama H, Ohnishi H, Hamada H, Nakajima M, Kohno N, Higaki J. Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice. Eur Respir J 2005, 25:653-659. 10.1183/09031936.05.00021304, 15802339.
40. de Paiva CS, Corrales RM, Villarreal AL, Farley WJ, Li D-Q, Stern ME, Pflugfelder SC. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci 2006, 47:2847-2856. 10.1167/iovs.05-1281, 16799024.
41. de Paiva CS, Raince JK, McClellan AJ, Shanmugam KP, Volpe EA, Corrales RM, Farley WJ, Corry DB, Li D-Q, Pflugfelder SC. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol 2010, 4:397-408. doi: 10.1038/mi.2010.82. Epub 2010 Dec 22.
42. Zhang X, Chen W, de Paiva CS, Volpe EA, Gandhi NB, Farley WJ, Li D-Q, Niederkorn JY, Stern ME, Pflugfelder SC. Desiccating stress induces CD4+ T-cell-mediated Sjogren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-{gamma}. Am J Pathol 2011, 179:1807-1814. Epub 2011 Aug 16, 10.1016/j.ajpath.2011.06.030, 3181354, 21843497.
43. Zhang X, Chen W, de Paiva CS, Corrales RM, Volpe EA, McClellan AJ, Farley WJ, Li D-Q, Pflugfelder SC. Interferon-{gamma} exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci 2011, 52:6279-6285. 10.1167/iovs.10-7081, 3176027, 21474767.
44. Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R, Ito S, Tsutsumi A, Sumida T. Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren's syndrome. Ann Rheum Dis 2005, 64:510-511. 1755406, 15708912.
45. Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol 1996, 104:454-459. 10.1046/j.1365-2249.1996.42748.x, 2200439, 9099930.
46. Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis. J Autoimmun 2010, 35:383-389. 10.1016/j.jaut.2010.08.004, 20864316.
47. Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, Dana R. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 2009, 182:1247-1252. 2630586, 19155469.
48. Nakahara M, Nagayama Y, Ichikawa T, Yu L, Eisenbarth GS, Abiru N. The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages. Autoimmunity 2011, 44:504-510. 10.3109/08916934.2010.548839, 21306188.